Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.

[1]  U. Capitanio,et al.  [18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab. , 2020, Urologic oncology.

[2]  Yuxuan Song,et al.  Development and Validation of a Nomogram to Predict Lymph Node Metastasis in Patients With T1 High-Grade Urothelial Carcinoma of the Bladder , 2020, Frontiers in Oncology.

[3]  S. Daneshmand,et al.  Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response. , 2020, Urologic oncology.

[4]  J. Witjes,et al.  European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. , 2020, European urology.

[5]  R. Nawroth,et al.  Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection. , 2020, Urologic oncology.

[6]  Simon P. Kim,et al.  Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model. , 2020, Urologic oncology.

[7]  M. Babjuk,et al.  EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. , 2019, European urology.

[8]  W. Oyen,et al.  EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Søren Høyer,et al.  Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up. , 2017, European urology focus.

[10]  F. Montorsi,et al.  Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer. , 2018, Urologic oncology.

[11]  Seong-Jang Kim,et al.  Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis , 2018, Oncology.

[12]  M. Amin,et al.  Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. , 2018, European Urology.

[13]  Tianxin Lin,et al.  A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer , 2018, EBioMedicine.

[14]  F. Montorsi,et al.  Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy , 2018, World Journal of Urology.

[15]  F. Montorsi,et al.  Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. , 2016, European urology focus.

[16]  A. Poprach,et al.  Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery. , 2018, Neoplasma.

[17]  Kyoungjune Pak,et al.  Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis , 2018, World Journal of Urology.

[18]  S. Shariat,et al.  Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery , 2016, Translational andrology and urology.

[19]  A. Briganti,et al.  The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder , 2016, Nature Reviews Urology.

[20]  Holger Moch,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. , 2016, European urology.

[21]  B. Haller,et al.  Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy , 2015, Urologia Internationalis.

[22]  Chia-Hao Chang.  Cohen's kappa for capturing discrimination. , 2014, International health.

[23]  D. Rubello,et al.  Diagnostic Accuracy of 11C-Choline PET/CT in Preoperative Lymph Node Staging of Bladder Cancer: A Systematic Comparison With Contrast-Enhanced CT and Histologic Findings , 2014, Clinical nuclear medicine.

[24]  Paolo Eusebi,et al.  Diagnostic Accuracy Measures , 2013, Cerebrovascular Diseases.

[25]  S. Daneshmand,et al.  Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. , 2012, Urology.

[26]  M. Schwaiger,et al.  Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. , 2012, European urology.

[27]  A. Graser,et al.  Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? , 2012, World Journal of Urology.

[28]  U. Capitanio,et al.  Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. , 2009, The Journal of urology.

[29]  V. Ficarra,et al.  Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma , 2005, BJU international.

[30]  M. Resnick,et al.  Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.

[31]  B. Gross,et al.  Upper abdominal lymph nodes: criteria for normal size determined with CT. , 1991, Radiology.

[32]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[33]  E. Spitznagel,et al.  ASA Physical Status Classifications: A Study of Consistency of Ratings , 1978, Anesthesiology.